CLINICAL TRIALS PROFILE FOR YOSPRALA
✉ Email this page to a colleague
All Clinical Trials for YOSPRALA
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00960869 ↗ | Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers | Completed | POZEN | Phase 3 | 2009-10-01 | Primary: To demonstrate that PA32540 causes fewer gastric ulcers in subjects at risk for developing aspirin-associated gastric ulcers compared to enteric coated (EC) aspirin 325 mg. |
| NCT00961350 ↗ | A Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers | Completed | POZEN | Phase 3 | 2009-10-01 | Primary: To demonstrate that PA32540 causes fewer gastric ulcers in subjects at risk for developing aspirin-associated gastric ulcers compared to enteric coated (EC) aspirin 325 mg. |
| NCT00995410 ↗ | Study to Evaluate the Long-Term Safety of PA32540 in Subjects Who Are at Risk for Developing Aspirin-Associated Gastric Ulcers | Completed | POZEN | Phase 3 | 2009-10-01 | This study uses an open-label design and will be conducted in approximately 40 sites in the United States. Approximately 400 subjects will be enrolled in the study to ensure that approximately 300 subjects will have 6 months exposure to PA32540 and at least 100 subjects will have 12 months exposure to PA32540. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for YOSPRALA
Condition Name
Clinical Trial Locations for YOSPRALA
Trials by Country
Clinical Trial Progress for YOSPRALA
Clinical Trial Phase
Clinical Trial Sponsors for YOSPRALA
Sponsor Name
